¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"curve of occlusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • equal loudness curve
    À½·®µî°¨°î¼±
  • equilibrium curve
    ÆòÇü°î¼±
  • flow volume curve
    À¯·®¿ë·®°î¼±
  • fluid velocity curve
    À¯¼Ó°î¼±
  • frequency curve
    µµ¼ö°î¼±
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±
  • frequency response curve
    Á֯ļö¹ÝÀÀ°î¼±
  • growth curve
    ¼ºÀå°î¼±
  • hemoglobin absorption curve
    Çì¸ð±Û·ÎºóÈí¼ö°î¼±
  • isodose curve
    µî¼±·®°î¼±
  • isoeffect curve
    µîÈ¿°ú°î¼±
  • isoresponse curve
    µî¹ÝÀÀ°î¼±
  • intensity duration curve
    °­µµ±â°£°î¼±
  • killing curve
    »ç¸ê°î¼±
  • learning curve
    ÇнÀ°î¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • equilibrium curve
    ÆòÇü°î¼±
  • exponential curve
    Áö¼ö°î¼±
  • extension curve
    ½ÅÀü°î¼±
  • flow volume curve
    À¯·®¿ë·®°î¼±
  • fluid velocity curve
    À¯¼Ó°î¼±
  • frenquency response curve
    Á֯ļö¹ÝÀÀ°î¼±
  • frequency curve
    µµ¼ö°î¼±
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±
  • growth curve
    ¼ºÀå°î¼±
  • hemoglobin absorption curve
    Ç÷»ö¼ÒÈí¼ö°î¼±
  • intensity duration curve
    °­µµ±â°£°î¼±
  • isodose curve
    µî¼±·®°î¼±
  • isoeffect curve
    µîÈ¿°ú°î¼±
  • isoresponse curve
    µî¹ÝÀÀ°î¼±
  • killing curve
    »ç¸ê°î¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • occlusion plane
    ±³ÇÕÆò¸é(ÎáùêøÁØü).
  • occlusion therapy
    °¡¸²Ä¡·á
  • opposite occlusion =progenia reversed o.
    ÇϾÇÀüµ¹(Áõ)(ù»äÉîñÔÍñø).
  • partial occlusion
    ºÎºÐ°¡¸²
  • percutaneous transhepatic variceal occlusion
    °æÇÇ °æ°£ Á¤¸Æ·ù Æó»ö¼ú
  • posterior occlusion
    ÈÄÃø±³ÇÕ(ÈÄÃø±³ÇÕ).
  • progenia =opposite occlusion
    ÇϾÇÀüµ¹(Áõ)(ù»äÉîñÔÍñø), ¹Ý´ë±³ÇÕ(ÚãÓß Îáùê).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â (¡­øÍáð).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â(øËð¡ØæøÍáð)
  • punctal occlusion
    ´«¹°Á¡Æó¼â, ´©Á¡Æó¼â
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö(ãìÔÑØæøÍßá).
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö(ãìÔÑØæøÍßá)
  • renal artery,occlusion of
    ¡­ÀÇ Æó¼â(øÍáð)
  • retinal artery occlusion
    ¸Á¸·µ¿¸ÆÆó»ö.
  • retinal vein occlusion
    ¸Á¸·Á¤¸ÆÆó¼â(¡­øÍáð).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
VFC ventricular function curve
CRAO Central Retina Artery Occlusion
ACO acute coronary occlusion; alert, cooperative, and oriented; anodal closure odor
BAVFO bradycardia after arteriovenous fistula occlusion
BICAO bilateral internal carotid artery occlusion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ROC Receiver Operator Characteristic Curve
ROC Receiver Operator Curve
TAC Time activity curve
TC Tuning curve
AUIC are under the inhibitory curve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • canine-protected occlusion
    °ßÄ¡ º¸È£¼º ±³ÇÕ
    µ¿ÀǾî=canine/cus
  • component of occlusion
    ±³ÇÕ ¿ä¼Ò
    ±³ÇÕ¿¡ °ü¿©ÇÏ´Â °¢Á¾ ¿ä¼Ò·Î ¾Ç°üÀý, ½Å°æ±Ù°è, Ä¡¾Æ°¡ Æ÷ÇԵǸç, ÀÇÄ¡¿¡ À־´Â ÀÇÄ¡ ÁöÁö ±¸Á¶°¡ Æ÷ÇԵȴÙ.
  • coronary occlusion
    °ü»ó µ¿¸Æ Æó¼â
  • cross bite occlusion
    ±³Â÷ ±³ÇÕ
  • cuspid protected occlusion
    °ßÄ¡ º¸È£¼º ±³ÇÕ
    µ¿ÀǾî=canine-
  • dynamic individual occlusion
    °³º°Àû µ¿Àû ±³ÇÕ
  • edge to edge occlusion
    Àý´Ü ±³ÇÕ
    »óÇÏ¾Ç ÀüÄ¡ÀÇ Àý´Ü¸éÀÌ ¸Â¹°¸®´Â ±³ÇÕ °ü°è.
  • ideal occlusion
    ÀÌ»ó ±³ÇÕ
    »ó¾ÇÄ¡ ¹× ÇϾÇÄ¡ÀÇ »óÈ£ ÇÔÀÔ ±³ÇÕÀÌ ¿Ïº®ÇÑ »óÅÂ.
  • individual normal occlusion
    °³¼º Á¤»ó ±³ÇÕ
    Á¤»ó º¯À̳»¿¡ ÀÖ´Â °³ÀÎÂ÷¸¦ ÀÎÁ¤ÇÏ´Â Á¤»ó±³ÇÕ
  • interference of occlusion
    ±³ÇÕ °£¼·
    µ¿ÀǾî=su
  • lateral occlusion
    Ãø¹æ ±³ÇÕ
    ÇϾǰñÀÌ Ãø¹æ ¿îµ¿À» Çϰí Ä¡¾ÆÀÇ ±³ÇÕ ¸éÀÌ ¿ìÃø ȤÀº ÁÂÃø¿¡¼­ Ãø¹æÀ¸·Î Á¢ÃËÀ§¸¦ À¯ÁöÇÏ¿© 3Á¡ Á¢ÃËÀÇ ±ÕÇü À§¿¡ ÀÖ´Â »óÅÂ.
  • mesial molar occlusion
    ±Ù½É ±¸Ä¡ ±³ÇÕ
  • monoplane occlusion
    ´ÜÀÏ Æò¸é ±³ÇÕ
  • mutually protected occlusion
    »óÈ£ º¸È£¼º ±³ÇÕ, »óÈ£ º¸È£ ±³ÇÕ
  • neutral occlusion
    Á¤»ó ±³ÇÕ
    µ¿ÀǾî=normal occlusion.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
edge-to-edge occlusion An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
torsive occlusion A malposition of a tooth in which it is rotated on its long axis.
Synonym: torsive occlusion, torsoclusion.
(05 Mar 2000)
end-to-end occlusion An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
traumatic occlusion A malocclusion capable of producing injury to the teeth and/or associated structures.
Synonym: traumatic occlusion.
(05 Mar 2000)
traumatogenic occlusion A malocclusion capable of producing injury to the teeth and/or associated structures.
Synonym: traumatic occlusion.
(05 Mar 2000)
labial occlusion Malposition of a tooth in a labial direction, the occlusion as seen from the labial side of the arches.
(05 Mar 2000)
lateral occlusion Malposition of a tooth or an entire dental arch in a direction away from the midline.
(05 Mar 2000)
functional occlusion Any tooth contacts made within the functional range of the opposing teeth surfaces, occlusion which occurs during function.
(05 Mar 2000)
line of occlusion The alignment of the occluding surfaces of the teeth in the horizontal plane.
See: occlusal plane.
(05 Mar 2000)
lingual occlusion Interdigitation of the teeth as seen from the internal or lingual aspect.
See: linguoclusion.
(05 Mar 2000)
active length-tension curve The relationship between active isometric tension and preload (rest length) for a contracting muscle.
(05 Mar 2000)
alignment curve The line passing through the centre of the teeth laterally in the direction of the curve of the dental arch.
(05 Mar 2000)
anti-Monson curve In dentistry, a curve of occlusion which is convex upward.
Synonym: anti-Monson curve.
(05 Mar 2000)
area under curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the auc from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies.
(12 Dec 1998)
area under the curve A measure of how much of a drug reaches the bloodstream in a set period of time, usually 24 hours. AUC is calculated by plotting drug blood concentration at various times during a 24-hour or longer period and then measuring the area under the curve between 0 and 24 hours as shown in the figure to the right.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á